Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
DGPRI, a new liver fibrosis assessment index, predicts recurrence of AFP-negative hepatocellular carcinoma after hepatic resection: a single-center retrospective study.
Sci Rep. 2024 May 10;14(1):10726. doi: 10.1038/s41598-024-61615-0.
Sci Rep. 2024.
PMID: 38730095
Free PMC article.
The MAPS-CRAFITY score: a novel efficacy predictive tool for unresectable hepatocellular carcinoma treated with targeted therapy plus immunotherapy.
Ouyang J, Yang Y, Zhou Y, Ye F, Wang Z, Li Q, Xu Y, Li L, Zhao X, Zhang W, Zhou A, Huang Z, Wang Y, Cai J, Zhao H, Zhou J.
Ouyang J, et al.
Hepatol Int. 2023 Dec;17(6):1519-1531. doi: 10.1007/s12072-023-10580-3. Epub 2023 Sep 14.
Hepatol Int. 2023.
PMID: 37707759
Item in Clipboard
Cite
Cite